| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $105.2M | $126.8M | $129.3M |
| YoY Revenue Growth % | -17.0% | -1.9% | — |
| Gross Profit | $11.9M | $14.5M | — |
| Gross Margin % | 11.3% | 11.4% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$486.6K | -$206.0K | $11.3M |
| Operating Margin % | -0.5% | -0.2% | 8.8% |
| Net Income (GAAP) | $820.0K | -$7.4M | $9.8M |
| EBITDA (Normalized) | -$464.9K | -$153.4K | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $1.2M | -$2.2M | $23.6M |
| Capital Expenditures (CapEx) | $27.2K | $65.9K | — |
| Free Cash Flow (FCF) | $1.2M | -$2.3M | $23.6M |
| FCF Margin % | 1.1% | -1.8% | 18.2% |
| Return on Invested Capital (ROIC %) | -40.8% | -45.0% | — |
| Cash & Short-Term Equivalents | $9.0M | $15.2M | — |
| Total Debt (Short + Long Term) | $2.2M | $2.2M | — |
| Total Stockholders' Equity | $7.8M | $7.1M | — |